Literature DB >> 23061029

The Impact of Depressive Symptoms on Neuropsychological Performance Tests in HIV-Infected Individuals: A Study of the Hawaii Aging with HIV Cohort.

Sheri M Shimizu1, Dominic C Chow, Victor Valcour, Kamal Masaki, Beau Nakamoto, Kalpana J Kallianpur, Cecilia Shikuma.   

Abstract

BACKGROUND: The frequency of neurocognitive impairment (NCI) in human immunodeficiency virus (HIV)-infected individuals remains high despite the availability of potent antiretroviral therapy (ART). The concurrence of depression among HIV-infected patients with NCI is common, especially among older individuals. Depression has been implicated as a risk factor for impaired neuropsychological performance (NP). This study explored the relationship between depressive symptoms and NP testing in HIV-infected individuals.
METHODS: A cross-sectional analysis was performed within the Hawaii Aging with HIV Cohort, a large prospective study of cognition of older (50 or more years old) compared to younger (20 to 39 years old) HIV-infected individuals.
RESULTS: Two hundred and eighty-five HIV infected participants (157 older and 128 younger) were administered a battery of NP tests to measure performance in major cognitive domains. Depressive symptoms were measured using the Beck Depression Inventory (BDI). The rates of depressive symptoms and neuropsychological impairment were similar in older and younger groups. Multivariate analyses revealed depressive symptoms were associated with NP test impairment in the younger group. In the older group, depressive symptoms were not associated with NP.
CONCLUSION: This study suggests that depressive symptoms are associated with NP test impairment in younger HIV-infected individuals, but not in older individuals.

Entities:  

Year:  2011        PMID: 23061029      PMCID: PMC3467015          DOI: 10.4236/wja.2011.14020

Source DB:  PubMed          Journal:  World J AIDS        ISSN: 2160-8814


  34 in total

1.  CDC surveillance report notes slowdown in new HIV/AIDS rates.

Authors: 
Journal:  AIDS Policy Law       Date:  2002-03-15

Review 2.  Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells.

Authors:  Vilhelm A Bohr
Journal:  Free Radic Biol Med       Date:  2002-05-01       Impact factor: 7.376

3.  Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals.

Authors:  B C Bix; G Glosser; W Holmes; C Ballas; M Meritz; C Hutelmyer; J Turner
Journal:  J Int Neuropsychol Soc       Date:  1995-11       Impact factor: 2.892

4.  Internal consistencies of the original and revised Beck Depression Inventory.

Authors:  A T Beck; R A Steer
Journal:  J Clin Psychol       Date:  1984-11

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIV-1 promoter sensitization.

Authors:  Tokio Yamaguchi; Iyoko Katoh; Shun-ichi Kurata
Journal:  Eur J Biochem       Date:  2002-06

7.  Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study.

Authors:  F K Judd; A M Cockram; A Komiti; A M Mijch; J Hoy; R Bell
Journal:  Aust N Z J Psychiatry       Date:  2000-12       Impact factor: 5.744

8.  Depression in people living with HIV/AIDS attending primary care and outpatient clinics.

Authors:  Angela Komiti; Fiona Judd; Paul Grech; Anne Mijch; Jennifer Hoy; Ben Williams; Alan Street; John H Lloyd
Journal:  Aust N Z J Psychiatry       Date:  2003-02       Impact factor: 5.744

9.  Cognitive functioning in younger and older HIV-1-infected adults.

Authors:  Frances L Wilkie; Karl Goodkin; Imad Khamis; Maria H van Zuilen; Diana Lee; Robert Lecusay; Mauricio Concha; Stephen Symes; Paola Suarez; Carl Eisdorfer
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

10.  Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus.

Authors:  R L Mapou; W A Law; A Martin; D Kampen; A M Salazar; J R Rundell
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

View more
  19 in total

1.  The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.

Authors:  Sapna M Patel; April D Thames; Natalie Arbid; Stella E Panos; Steven Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2013-04-03       Impact factor: 2.475

Review 2.  Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV.

Authors:  Raeanne C Moore; Pariya L Fazeli; Dilip V Jeste; David J Moore; Igor Grant; Steven Paul Woods
Journal:  AIDS Behav       Date:  2014-06

Review 3.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

4.  Mindfulness-based stress reduction for HIV-associated neurocognitive disorder: Rationale and protocol for a randomized controlled trial in older adults.

Authors:  Elizabeth L Addington; Shireen Javandel; Victor De Gruttola; Robert Paul; Benedetta Milanini; Beau M Ances; Judith T Moskowitz; Victor Valcour
Journal:  Contemp Clin Trials       Date:  2020-09-15       Impact factor: 2.226

5.  Major depressive disorder, cognitive symptoms, and neuropsychological performance among ethnically diverse HIV+ men and women.

Authors:  Robert P Fellows; Desiree A Byrd; Susan Morgello
Journal:  J Int Neuropsychol Soc       Date:  2013-01-04       Impact factor: 2.892

6.  Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.

Authors:  Benedetta Milanini; Stephanie Catella; Brandon Perkovich; Pardis Esmaeili-Firidouni; Lauren Wendelken; Robert Paul; Meredith Greene; Robin Ketelle; Victor Valcour
Journal:  AIDS Care       Date:  2017-01-27

7.  Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.

Authors:  Ned Sacktor; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; M Kate Grabowski; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

Review 8.  Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways.

Authors:  F B Del Guerra; J L I Fonseca; V M Figueiredo; E B Ziff; E Castelon Konkiewitz
Journal:  J Neurovirol       Date:  2013-07-19       Impact factor: 2.643

9.  HIV Clade-C Infection and Cognitive Impairment, Fatigue, Depression, and Quality of Life in Early-Stage Infection in Northern Indians.

Authors:  R Cook; D L Jones; R Nehra; A M Kumar; S Prabhakar; D Waldrop-Valverde; S Sharma; M Kumar
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-30

10.  Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.

Authors:  Idil Kore; Jintanat Ananworanich; Victor Valcour; James L K Fletcher; Thep Chalermchai; Robert Paul; Jesse Reynolds; Somporn Tipsuk; Sasiwimol Ubolyam; Somprartthana Rattanamanee; Linda Jagodzinski; Jerome Kim; Serena Spudich
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.